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Chagas diseaseWeapplied the respiratory sinus arrhythmia (RSA) quantiﬁcation algorithm to 24-hour ECG recordings of Chagas
disease (ChD) patients with (G1, n = 148) and without left ventricular dysfunction (LVD) (G2, n = 33), and
in control subjects (G0, n = 28). Both ChD groups displayed a reduced RSA index; G1 = 299 (144–812);
G2 = 335 (162–667), p = 0.011, which was correlated with vagal indexes of heart rate variability analysis.
RSA index is a marker of vagal modulation in ChD patients.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Chagas disease (ChD) is an important cause of cardiac disease in en-
demic areas of Latin America and, due to migratory movements of in-
fected individuals, it has recently also become a cause for concern in
the United States and Europe (Machado et al., 2012). Diffuse damage
to the autonomic nervous system, primarily the parasympathetic
branch of the heart and the digestive tract, is an important pathological
feature in patients with ChD in both the acute and chronic phase
(Guzzetti et al., 1991; Ribeiro et al., 2007).
Respiratory sinus arrhythmia (RSA) is synchronization between
heart rate (HR) and respiratory cycles mediated primarily by cardiac
vagal efferent trafﬁc (Eckberg, 1983). Peltola et al. (2008) have devel-
oped a method to quantify respiratory-speciﬁc HR ﬂuctuations on ECG
recordings without a simultaneous respiration signal. They observed
that reduced respiratory-related HR dynamic, detected with RSA
index, is a speciﬁc marker of an increased risk of sudden cardiac death
among post infarction patients.We applied the RSA quantiﬁcation algo-
rithm (Peltola et al., 2008) to 24-hour ECG recordings from patients
with ChD. Our aim was to assess heart rate autonomic control withates that there is no conﬂict of
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Belo Horizonte, Minas Gerais,RSA index in ChD patients with andwithout left ventricular dysfunction
(LVD).2. Methods
This was a cross-sectional study involving patients recruited in
1998–99 at the University Hospital of the Universidade Federal de
Minas Gerais. Informed consent was obtained from each patient, and
the study protocol conformed to current ethical guidelines and was ap-
proved by the Institutional Human Research Committee.
Patients with andwithout ChD aged 18 to 60 years-old whose initial
evaluation did not suggest the presence of other cardiac or signiﬁcant
systematic diseases were recruited. The exclusion criteria consisted of
unavailability for study participation, pregnancy and other cardiac or
systematic illnesses, as described elsewhere (Ribeiro et al., 2007). Indi-
viduals were considered to have ChD if they presented at least two pos-
itive serology tests for Trypanosoma cruzi using differentmethods. Non-
ChD controls should have at least three different serology tests for
T. cruzi and no signiﬁcant abnormalities on clinical and complementary
examinations, including routine laboratory tests, chest X-ray and ECG.
The study samplewas divided into three groups: group 0 (n=28), con-
trol subjects; group 1 (n= 148), patientswith ChD and normal left ven-
tricular ejection fraction (LVEF) (N50%); and group 2 (n = 33), and
patients with ChD with reduced LVEF (≤50%). Since we excluded
other cardiac and systemic disease, we consider that the low LVEF in
ChD patients could be attributed to Chagas cardiomyopathy. General
features, heart rate variability (HRV) indexes and RSA index were com-
pared among ChD and control groups.
Table 1
Comparison of the demographic, clinical, echocardiographic, and electrocardiographic da-
ta of Chagas disease patients and control groups.
Control 0 Group 1 Group 2 p value
n = 28 n = 148 n = 33
Male 19/9 81/67 21/12
Age 40 ± 11 42 ± 10 44 ± 11 0.19
LVEF 64 ± 3 62 ± 4 39 ± 8 b0.001 0 = 1 b 2
NYHA functional class
I 28/28 126/148 17/33 b0.001
II 0/28 10/148 11/33
III 0/28 3/148 0/33
IV 0/28 1/148 0/33
Cardiothoracic
ratio
0.43 ± 0.04 0.45 ± 0.05 0.50 ± 0.05 b0.01 0 = 1 b 2
Right bundle-
branch block
00/28 42/148 14/33 b0.001 0 N 1 = 2
Ventricular extra
systoles
00/28 7/148 10/33 b0.001 0 N 1 N 2
Apical aneurysm 00/28 16/148 11/33 b0.001 0 N 1 N 2
Mild esophageal
motility
disturbance
00/28 32/148 6/33 b0.05 0 N 1 = 2
Values are expressed as mean ± SD or as proportions. Group 0, control group; group 1,
patients with ChD and normal left ventricular ejection fraction (LVEF) (b50%); and
group 2, patients with ChD and with reduced LVEF (50%). NYHA, New York Heart
Association.
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Fukuda Denshi, Tokyo, Japan) and analyzed and coded in a blinded and
standardized manner, as described elsewhere (Ribeiro et al., 2007). All
echocardiogram examinations were performed and analyzed by an ex-
perienced echocardiographer blinded to other data using a HDI 5000
(ATL, Bothell, Washington, DC) according to standard recommenda-
tions; LVEF was calculated using the Simpson method.
Twenty-four-hour Holter monitoring was performed using a porta-
ble three-channel cassette tape recorder (Dynamis, Cardios, São Paulo,
Brazil). The individuals were encouraged to continue with their normal
everyday activities during the recordings while avoiding physical exer-
cise and drugs that could interfere with autonomic function. The tapes
were analyzed when at least 18 h of good-quality tracings were avail-
able. The recordings were analyzed on a Burdick/DMI/Cardios Hospital
Holter System (Spacelabs Burdick, Deerﬁeld, Wisconsin/Cardios, São
Paulo, Brazil) using a semi-automatic technique. The sampling rate of
this system is 200 Hz. The following timedomain indexeswere calculat-
ed:mean heart rate, standard deviation of RR intervals (SDNN) and root
mean square of the sum of squares of differences between adjacent RR
intervals (RMSSD) (Task Force, 1996).
Spectral analysis of HRV was computed using fast Fourier
transformation (Burdick HRV software) and expressed as total power
(0.01–1.00 Hz) and low (LF, 0.04–0.15 Hz) and high (HF,
0.15–0.40 Hz) frequency components. In order to minimize non-
stationary oscillations of HRV, spectral analysis was performed during
sleep, in a 5-min segment of good quality and without ectopic beats,
close to the lowest heart rate. This night period, near the lowest heart
rate, in which the lowest sympathetic interference was expected, was
chosen in order to permit an efﬁcient comparison of thedifferent groups
(Ribeiro et al., 2005, 2007).
We used a previously developed and validated RSA algorithm
(Peltola et al., 2008) to quantify the variation in RR intervals attributed
to the respiratory inﬂuence during 24-hour Holtermonitoring. RR inter-
val time series were extracted from Holter monitoring tests described
above and sent to the Division of Cardiology, Department of Internal
Medicine, University of Oulu, to be processed. RR interval time series
containing ectopic beats and other disturbances were edited with the
interpolation of degree zero. The average number of obtained RSA seg-
mentswas 13±6,which corresponded to approximately 72min of ECG
recording when the average duration of one RSA segment was 5 min
and 35 s.
The data were analyzed using the SPSS statistical package for Win-
dows, version 19 (SPSS, Chicago, IL). The chi-square test was used to
compare categorical variables among groups, and one-way ANOVA
with Duncan's correction was used to compare continuous variables.
HF, LF and RSA indexes were log transformed. Pearson's correlation co-
efﬁcientwas used tomeasure correlations betweenRSA andHRV index-
es. The signiﬁcance level was set at P b 0.05.
3. Results
Demographic, clinical, echocardiographic, and electrocardiographic
data of the ChD patients and control groups are presented in Table 1.
Table 2 shows the HRV indexes and RSA index in study groups. The
meanHRwas higher in group 0 than in groups 1 and 2, but not different
between ChD groups (p= 0.007). RMSSD and SDNNwere not different
between groups (p= 0.56 and p= 0.58, respectively). HF was signiﬁ-
cantly higher in group 0 compared with groups 1 and 2 (p b 0.001,
Table 2), but there was no difference between groups in relation
to total power (p = 0.78), LF (p = 0.06) or LF/HF ratio (p = 0.05).
RSA index was higher in group 0 compared with groups 1 and 2
(p = 0.011), and there were no differences between ChD groups. RSA
was strongly associated with all HRV indexes and showed higher corre-
lation coefﬁcients with the vagal HRV indexes HF (Group 0, r= 0.873,
p b 0.001; ChD Patients r = 0.541, p b 0.001) and RMSSD (Group 0,
r = 0.830, p b 0.001; ChD Patients, r = 0.794, p b 0.001). The SDNNwas strongly associated with RSA index in control group (r = 0.768,
p b 0.001) and moderate in ChD patients (r= 0.544, p b 0.001). There
was a moderate correlation between RSA index and LF in control
group (r = 0.561, p b 0.071) and a weak correlation in ChD patients
(r= 0.271, p b 0.002).
4. Discussion
In this study, a novel method of evaluation of vagal modulation of
the heart, the RSA index, was used to compare ChD patients with and
without LVD and healthy subjects. RSA index was highly correlated
with vagal HRV indexes HF and RMSSD and reduced in both groups of
ChD patients, with and without LV systolic dysfunction. This result cor-
roborates our previous studies that parasympathetic dysautonomia pre-
cedes LVD in ChD (Ribeiro et al., 2001, 2005, 2007).
The magnitude of RSA-related HF ﬂuctuation has been suggested to
provide an index that may describe vagal modulation of the heart
(Eckberg, 1983). During sleep, there is a predominance of vagal activity,
although during rapid eye movement (REM) sleep stage occurs in-
creased sympathetic activity; thus nocturnal 24 h Holter derived HRV
indexesmight reﬂectmainly vagal inﬂuences (Task Force, 1996). Never-
theless, the spectral analysis has some limitations because it can identify
erratic oscillations that affect HF spectra and produce a bias in the quan-
tiﬁcation of RSA using standard 24-hour HF spectral analysis methods.
Thus, to overcome this limitation, Peltola et al. (2008) quantiﬁed
RSA index by designing and implementing an algorithm that only
emphasizes the respiratory-associated RR interval variations during a
24-hour ECG recording. Depressed RSA index was a speciﬁc indicator
of increased risk for sudden cardiac death, even after adjustments for
signiﬁcant clinical risk factors, in 1631 myocardial infarction patients
with a follow-up of 40 ± 17 months (Peltola et al., 2008).
In our study, the reduced RSA index found in ChD patients with and
without LVDmay indicate a loss of synchronization between HR and re-
spiratory cycles, whichmay be related to impaired vagalmodulation on
heart. Previous studies have shown that vagal dysautonomia is an early
and primary phenomenon in ChD (Ribeiro et al., 2001, 2005, 2007). In
addition, RSA index was reduced in ChD patients independent of the
presence of LVD compared with control subjects. This phenomenon
may be related to the relatively inability of RSA to track severity of
vagal modulation impairment, as observed in diabetic autonomic
Table 2
Comparison of the heart rate variability index of Chagas disease patients with normal and reduced LVEF and control group.
Group 0 Group 1 Group 2 p value
n = 28 n = 148 n = 33
Time domain
Mean HR (bpm) 79.20 ± 5.23 73.73 ± 9.72 71.80 ± 10.68 0.007 0 N 1 = 2
SDNN (ms) 148.82 ± 46.49 147.50 ± 36.81 154.26 ± 40.29 0.56
RMSSD (ms) 40.30 ± 19.81 38.97 ± 22.41 36.56 ± 22.07 0.58
Frequency domain
Total power (ms2)* 4238 (1892–9871) 2230 (1033–4896) 3869 (1307–6664) 0.78
HF (ms2)* 1018 (501–2296) 297 (131–597) 415 (241–504) b0.001 0 N 1 = 2
LF (ms2)* 934 (427–2802) 473 (292–1103) 460 (374–830) 0.06
LF/HF* 0.90 (0.49–2.09) 1.98 (0.77–3.29) 1.16 (0.88–2.68) 0.05
RSA
RSA index* 1011 (288–2252) 299 (144–812) 335 (162–667) 0.011 0 N 1 = 2
Values are expressed as themean (SD)when appropriate, except*, which is expressed as themedian (25%–75%). Group 0, control group; group 1, patients with ChD and normal left ven-
tricular ejection fraction (LVEF) (b50%); and group2, patientswith ChD and reduced LVEF (N50%);meanHR,mean heart rate; SDNN, standard deviation of RR intervals; RMSSD, rootmean
square of successive differences; HF, high frequency; LF, low frequency; LF/HF, low-to-high-frequency component ratio; RSA index, Respiratory Sinus Arrhythmia Index log transformed.
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severity of vagal dysfunction and left ventricular function remains
controversial.
We observed a strong positive correlation between RSA and vagal
indexes of HRV (RMSSD andHF) in all studied groups. Indeed, this result
conﬁrmed that RSA index has an important relation to vagalmodulation
(Eckberg, 1983), and therefore, it can be used as index of vagal modula-
tion. Furthermore, therewas a signiﬁcantweak correlation between the
RSA index and LF. This ﬁnding can be explained because the HRV re-
cording was made at night around the lowest HR, i.e., during maximal
vagal activity. In this situation, LF power is not a reliable index of sympa-
thetic tonus and may also reﬂect parasympathetic modulation of the
sinus node as well as non-neural inﬂuences (Ribeiro et al., 2007;
Rahman et al., 2011). Therefore, if its applicability is conﬁrmed in fur-
ther studies, the RSA index could be used as a more speciﬁc marker of
vagal modulation than the HF component because RSA does not assess
the non-respiratory component.
One of the main limitations of this study is the absence of a respira-
tory signal, which could increase the likelihood of the selected RR inter-
val segments being affected only by respiration (Peltola et al., 2008).We
did not evaluate the sleep stage in which the 5-min spectral analysis
was performed and we cannot exclude the possibility of having record-
ed the ECG during the REM stage, inwhich increased sympathetic mod-
ulation occur.Moreover, more studies are necessary to conﬁrmwhether
the new index also has prognostic value in Chagas cardiomyopathy.
In conclusion, our data indicate that the RSA index could be a useful
marker of vagal modulation of the heart in patients with ChD.
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